(Q61510034)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

Phase I trial of BCL-2 antisense oligonucleotide (G3139) administered by continuous intravenous infusion in patients with advanced cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

main subject

phase I clinical trial

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

8

Karen Siedlecki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

7

Kathryn L Terry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

3

Carlos Cordon-Cardo

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

13

Howard I Scher

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

6

Susan F Slovin

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

author name string

Michael J Morris

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

William P Tong

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

William K Kelly

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Paul Swanson

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Mohmed Rafi

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Robert S DiPaola

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Neal Rosen

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

language of work or name

English

0 references

publication date

1 March 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

published in

Clinical Cancer Research

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

679-683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11895895%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

Identifiers

1 reference